Annual Total Long Term Liabilities
$82.54 M
+$82.25 M+27975.85%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual total long term liabilities is $82.54 million, with the most recent change of +$82.25 million (+27975.85%) on December 31, 2023.
- During the last 3 years, GYRE annual total long term liabilities has risen by +$80.91 million (+4952.21%).
- GYRE annual total long term liabilities is now at all-time high.
Performance
GYRE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$12.05 M
+$41.00 K+0.34%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly total long term liabilities is $12.05 million, with the most recent change of +$41.00 thousand (+0.34%) on September 30, 2024.
- Over the past year, GYRE quarterly long term liabilities has dropped by -$70.49 million (-85.40%).
- GYRE quarterly long term liabilities is now -85.40% below its all-time high of $82.54 million, reached on December 31, 2023.
Performance
GYRE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
GYRE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | -85.4% |
| 3 y3 years | +4952.2% | +1040.6% |
| 5 y5 years | +4952.2% | +1040.6% |
GYRE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -85.4% | +1040.6% |
| 5 y | 5-year | at high | >+9999.0% | -85.4% | +1040.6% |
| alltime | all time | at high | >+9999.0% | -85.4% | +1040.6% |
Gyre Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.05 M(+0.3%) |
| Jun 2024 | - | $12.01 M(-12.7%) |
| Mar 2024 | - | $13.75 M(-83.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $82.54 M(>+9900.0%) | $82.54 M(+7712.9%) |
| Mar 2023 | - | $1.06 M |
| Dec 2022 | $294.00 K(-82.0%) | - |
| Dec 2021 | $1.63 M | - |
FAQ
- What is Gyre Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Gyre Therapeutics?
- What is Gyre Therapeutics annual total long term liabilities year-on-year change?
- What is Gyre Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly long term liabilities year-on-year change?
What is Gyre Therapeutics annual total long term liabilities?
The current annual total long term liabilities of GYRE is $82.54 M
What is the all time high annual total long term liabilities for Gyre Therapeutics?
Gyre Therapeutics all-time high annual total long term liabilities is $82.54 M
What is Gyre Therapeutics annual total long term liabilities year-on-year change?
Over the past year, GYRE annual total long term liabilities has changed by +$82.25 M (+27975.85%)
What is Gyre Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of GYRE is $12.05 M
What is the all time high quarterly long term liabilities for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly total long term liabilities is $82.54 M
What is Gyre Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, GYRE quarterly total long term liabilities has changed by -$70.49 M (-85.40%)